Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 134
2021 1579
2022 571
2023 243
2024 740

Search Results

2,978 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Munro APS, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, Enever Y, Gokani K, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kwok J, Lambe T, Libri V, Llewelyn MJ, McGregor AC, Minassian AM, Moore P, Mughal M, Mujadidi YF, Murira J, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Salkeld J, Saralaya D, Sharma S, Sheridan R, Sturdy A, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Nguyen-Van-Tam JS, Snape MD, Liu X, Faust SN; COV-BOOST study group. Munro APS, et al. Lancet. 2021 Dec 18;398(10318):2258-2276. doi: 10.1016/S0140-6736(21)02717-3. Epub 2021 Dec 2. Lancet. 2021. PMID: 34863358 Free PMC article. Clinical Trial.
Vaccine hesitancy in the era of COVID-19.
Troiano G, Nardi A. Troiano G, et al. Public Health. 2021 May;194:245-251. doi: 10.1016/j.puhe.2021.02.025. Epub 2021 Mar 4. Public Health. 2021. PMID: 33965796 Free PMC article. Review.
Administration of COVID-19 vaccines in immunocompromised patients.
Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Negahdaripour M, et al. Int Immunopharmacol. 2021 Oct;99:108021. doi: 10.1016/j.intimp.2021.108021. Epub 2021 Jul 28. Int Immunopharmacol. 2021. PMID: 34352567 Free PMC article. Review.
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.
Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, Tschöpe C, Kelle S, Poland GA, Frustaci A, Klingel K, Martin P, Hare JM, Cooper LT, Pantazis A, Imazio M, Prasad S, Lüscher TF. Heidecker B, et al. Eur J Heart Fail. 2022 Nov;24(11):2000-2018. doi: 10.1002/ejhf.2669. Epub 2022 Oct 6. Eur J Heart Fail. 2022. PMID: 36065751 Free PMC article. Review.
COVID-19 Vaccines in Children and Adolescents.
Committee on Infectious Diseases. Committee on Infectious Diseases. Pediatrics. 2022 Jan 1;149(1):e2021054332. doi: 10.1542/peds.2021-054332. Pediatrics. 2022. PMID: 34972217 Free PMC article. No abstract available.
COVID-19 vaccines: Global challenges and prospects forum recommendations.
Boudjelal M, Almajed F, Salman AM, Alharbi NK, Colangelo M, Michelotti JM, Olinger G, Baker M, Hill AVS, Alaskar A. Boudjelal M, et al. Int J Infect Dis. 2021 Apr;105:448-451. doi: 10.1016/j.ijid.2021.02.093. Epub 2021 Feb 27. Int J Infect Dis. 2021. PMID: 33652065 Free PMC article.
2,978 results